These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 984152

  • 1. The effect of promethazine hydrochloride on fetal and maternal lymphocytes.
    Gusdon JP, Herbst GA.
    Am J Obstet Gynecol; 1976 Nov 15; 126(6):730-1. PubMed ID: 984152
    [No Abstract] [Full Text] [Related]

  • 2. The treatment of erythroblastosis with promethazine hydrochloride.
    Gusdon JP.
    J Reprod Med; 1981 Sep 15; 26(9):454-8. PubMed ID: 7288746
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Promethazine hydrochloride therapy in severely Rh-sensitized pregnancies.
    Charles AG, Blumenthal LS.
    Obstet Gynecol; 1982 Nov 15; 60(5):627-30. PubMed ID: 6815600
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Possible effect of maternal promethazine therapy on neonatal immunologic functions.
    Rubinstein A, Eidelman AI, Melamed J, Gartner LM, Kandall S, Schulman H.
    J Pediatr; 1976 Jul 15; 89(1):136-8. PubMed ID: 1084418
    [Abstract] [Full Text] [Related]

  • 10. [Manifest feto-placental anasarca, treated in utero with success].
    Bierme R, Bierme S, Fournié R, Combel R.
    Bull Fed Soc Gynecol Obstet Lang Fr; 1967 Jul 15; 19(3):281. PubMed ID: 5586740
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppression of Rh isoimmunization. A review.
    Bowman JM.
    Obstet Gynecol; 1978 Oct 15; 52(4):385-93. PubMed ID: 101918
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prophylaxis and prenatal treatment of fetal erythroblastosis in pregnancy. A trial of polyvinylpyrrolidone. Preliminary report].
    Fuleston JE, Curto AD, De Dahinten N.
    Prensa Med Argent; 1965 Jun 18; 52(21):1370-1. PubMed ID: 5891784
    [No Abstract] [Full Text] [Related]

  • 16. [The role of the factors of blood group incompatibility of mother and fetus].
    Tabolin VA.
    Vestn Akad Med Nauk SSSR; 1966 Jun 18; 21(6):84-91. PubMed ID: 5999650
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Controlled trial of antenatal barbiturates in rhesus haemolytic disease.
    Towers SH, McMullin GP.
    Arch Dis Child; 1977 Apr 18; 52(4):324-5. PubMed ID: 324407
    [No Abstract] [Full Text] [Related]

  • 19. [Therapy of fetal Rh-erythroblastosis using the enzyme inductor combination of phenobarbital-nicethamide].
    Kintzel HW, Hinkel GK, Schwarze R, Händel A, Böttger D.
    Dtsch Gesundheitsw; 1972 Jul 27; 27(30):1405-8. PubMed ID: 4673197
    [No Abstract] [Full Text] [Related]

  • 20. [Current treatment of fetal erythroblastosis].
    Gligorović S, Gligorović V, Radojković Z, Majstorović M, Lopicić L, Marković P, Ivanović L, Janev A, Erac O.
    Bilt Hematol Transfuz; 1977 Jul 27; 5(1):43-9. PubMed ID: 921731
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.